Industrial Markets
The Tablet: EU competition authorities' recent focus on the pharmaceutical industry
This edition of The Tablet highlights the recent scrutiny of the EU competition authorities on the pharmaceutical sector and steps companies should be prepared to take in response to information requests.
Summary points:
- Following the Interim Report into the Sector Inquiry, pharmaceutical companies may face further questions and investigation from the Competition Authorities
- Pharmaceutical companies may be required to disclose information upon request from across their organization
- The proliferation of electronic documents especially in email means that the collection and production of information can prove to be a complex issue
- Companies need to have an effective response plan in place, as well as the ability to react quickly and effectively to information requests
A copy of the publication can be downloaded by clicking on the link below.
